Anatomic Stage IIIA Breast Cancer AJCC v8 Recruiting Phase 2 / 3 Trials for Perflutren (DB00556)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04715958Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure EstimationDiagnostic